MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jambio/lxaf063

Медицинская библиотека · Journal of applied microbiology · 2025

Integrating genomic, transcriptomic, and phenotypic information to explore drug resistance in Mycobacterium tuberculosis sub-lineage 4.2.2.2.

Hailemariam Tesfaye Gebreyohannis, Ayele Abaysew, Gelanew Tesfaye, Atnafu Abay, Brennan Michael, Tilahun Melaku, Alemayehu Dawit Hailu, Debella Zemedkun Abebe, Merid Yared, Shibeshi Workineh, Aseffa Abraham, Bobosha Kidist, Hirutu Yonas, Waddell Simon J, Engidawork Ephrem

СтатьяПеревод в очереди

Аннотация

AIMS: Mycobacterium tuberculosis (Mtb) remains a major global health challenge, particularly due to increasing drug resistance. Beyond the well-characterized mutations, the mechanisms involved in driving resistance appear to be more complex. This study investigated the differential gene expression of Ethiopian drug-resistant Mtb sub-lineage 4.2.2.2 clinical isolates through an integrated approach combining phenotypic, transcriptomic, and genomic analyses.

METHOD AND

RESULTS

RNA sequencing was performed by isolating RNA from six Mtb strains (three drug-sensitive and three drug-resistant) during mid-logarithmic phase growth. Drug resistance was assessed through whole-genome analysis and phenotypic testing using the BACTEC Mycobacteria growth indicator tube (MGIT)™ 960 system. RNA profiling revealed significantly reduced expression of six genes: Rv0096, Rv2780, Rv3136, Rv3136A, Rv3137, and Rv3230c in drug-resistant isolates. These genes are not associated with known drug targets nor resistance mechanisms. Additionally, a discrepancy was noted between phenotypic resistance profiles and whole genome-based predictions, with the latter suggesting broader resistance. For instance, the missense mutation in rpoB p.Ser450Leu and katG p.Ser315Thr were identified with no change in phenotypic drug sensitivity to rifampicin and isoniazid, respectively.

CONCLUSION

Identification of these differentially expressed genes and their networks could be useful in unraveling the complexities of Mtb drug resistance and in understanding the impact that drug resistance conferring mutations have on the physiology of drug-resistant Mtb.

Для цитирования: Hailemariam Tesfaye Gebreyohannis, Ayele Abaysew, Gelanew Tesfaye, Atnafu Abay, Brennan Michael, Tilahun Melaku, Alemayehu Dawit Hailu, Debella Zemedkun Abebe, Merid Yared, Shibeshi Workineh, Aseffa Abraham, Bobosha Kidist, Hirutu Yonas, Waddell Simon J, Engidawork Ephrem. Integrating genomic, transcriptomic, and phenotypic information to explore drug resistance in Mycobacterium tuberculosis sub-lineage 4.2.2.2.. Journal of applied microbiology. 2025. DOI: 10.1093/jambio/lxaf063.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.